Current status and perspectives in immunotherapy for metastatic melanoma

Metastatic melanoma was the first malignancy in which immune checkpoint inhibitors demonstrated their successful efficacy. Currently, the knowledge on the interaction between the immune system and malignant disease is steadily increasing and new drugs and therapeutic strategies are overlooking in th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Principais autores: Marconcini, Riccardo, Spagnolo, Francesco, Stucci, Luigia Stefania, Ribero, Simone, Marra, Elena, Rosa, Francesco De, Picasso, Virginia, Di Guardo, Lorenza, Cimminiello, Carolina, Cavalieri, Stefano, Orgiano, Laura, Tanda, Enrica, Spano, Laura, Falcone, Alfredo, Queirolo, Paola
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5844761/
https://ncbi.nlm.nih.gov/pubmed/29552325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23746
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados